FCM Analysis GR in Steroid-Treatment Patients

NCT00600652 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2008-01-25

No results posted yet for this study

Summary

Monitoring the GR with a GR-MoAb and FITC-Dex probes by FCM would be useful and convenient in determination GR before the steroid treatment in clinical, especially in steroid resistant states, in order to design more efficient clinical treatment protocols.

Conditions

  • Healthy

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Jing Li, professor · Changhai Hospital

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2010-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00600652 on ClinicalTrials.gov